The global antibiotic drugs market is currently undergoing a significant transformation. As a leading Antibiotic Drugs Manufacturer & Factory, we recognize that the demand for high-quality antimicrobial agents is no longer just about volume—it is about precision, safety, and combating antimicrobial resistance (AMR). The global market size for antibiotics is projected to surpass $60 billion by 2030, driven by the increasing prevalence of infectious diseases and the rising demand for animal protein worldwide.
Modern factories are shifting away from traditional batch processing toward continuous manufacturing and AI-driven quality control. As an Antibiotic Drugs Manufacturer at the forefront of this change, Hangzhou Jeci Biochem Technology integrates smart monitoring systems to ensure that every batch of injectable or soluble powder meets stringent international pharmacopeia standards (USP, BP, or EP). The trend is moving toward "Green Chemistry," where synthetic processes are optimized to reduce environmental impact while maintaining high yield and cost-effectiveness.
Our high-purity Enrofloxacin (CAS 93106-60-6) represents the pinnacle of our synthetic capabilities. Designed for poultry and livestock, this broad-spectrum antibiotic is a cornerstone in modern veterinary medicine. By leveraging advanced crystallization techniques, we ensure 99% purity, which translates to better solubility and higher bioavailability in field applications.
Key Application: Respiratory and enteric infections in large-scale poultry farming.
Global buyers, from large pharmaceutical distributors in Southeast Asia to livestock cooperatives in South America, share a common requirement: Supply Chain Resilience. In a post-pandemic world, procurement officers are looking for factories that offer more than just a product; they need partners who provide regulatory support, custom labeling (OEM), and localized formulation advice.
In regions like India and Vietnam, the demand for injectable antibiotics like Tylosin Tartrate and Gentamicin is surging due to the intensification of cattle and pig farming.
With the rise of shrimp and fish farming in coastal regions, soluble antibiotic powders that can be easily mixed with feed are becoming essential for preventing mass-mortality events caused by bacterial outbreaks.
Multinational companies are increasingly outsourcing the production of advanced intermediates to Chinese factories to leverage high-tech infrastructure and lower operational costs.
China remains the powerhouse of global antibiotic production. At Hangzhou Jeci Biochem Technology Co., Ltd., our advantage lies in our geographic location—Hangzhou, a hub of biotech innovation—and our integrated supply chain. We don't just manufacture; we innovate. Our proximity to major shipping ports like Ningbo and Shanghai ensures that we can provide rapid international delivery, reducing lead times for our global partners.
Moving beyond simple bacterial control, our R&D team has developed complex formulations like the Butafosfan + Vitamin B12 Injection. This product illustrates our shift toward holistic animal health. By combining a potent organic phosphorus source with essential vitamins, we help livestock recover faster from antibiotic treatments, effectively bridging the gap between therapy and productivity.
Optimized for: Stress recovery in cattle, sheep, and swine after long-distance transport or disease.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Production Application
Drugs and intermediates are widely used in the following aspects (partial):
Production Equipment
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization.
For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
As a professional Antibiotic Drugs Factory, Jeci Biochem is investing heavily in synthetic biology and enzymatic catalysis. These technologies allow us to produce complex antibiotic molecules more efficiently and with significantly fewer by-products. This is crucial for the pharmaceutical industry's move toward sustainability. Furthermore, our digital manufacturing platform allows for real-time tracking of batches, providing our clients with unprecedented transparency into the manufacturing process.
Our commitment to excellence extends beyond the laboratory. We understand that in the global market, regulatory compliance is the ticket to entry. Whether it is navigating the complexities of COPP (Certificate of Pharmaceutical Product) or providing comprehensive dossiers for product registration, our dedicated regulatory affairs team is here to ensure that our products can be seamlessly integrated into your local market.
SJ medical
